Penserra Capital Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,645
| Closed | -$45K | – | 1581 |
|
|
2021
Q3 | $45K | Buy |
1,645
+15
| +0.9% | +$410 | ﹤0.01% | 1080 |
|
|
2021
Q2 | $48K | Buy |
1,630
+20
| +1% | +$589 | ﹤0.01% | 1014 |
|
|
2021
Q1 | $44K | Buy |
1,610
+85
| +6% | +$2.32K | ﹤0.01% | 832 |
|
|
2020
Q4 | $43K | Buy |
1,525
+961
| +170% | +$27.1K | ﹤0.01% | 712 |
|
|
2020
Q3 | $14K | Buy |
+564
| New | +$14K | ﹤0.01% | 787 |
|